Symbols / CTOR Stock $0.87 -0.15% Citius Oncology, Inc.

Healthcare • Drug Manufacturers - Specialty & Generic • United States • NCM
CTOR (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Mr. Leonard L. Mazur
Exch · Country NCM · United States
Market Cap 76.53M
Enterprise Value 73.61M
Income -23.64M
Sales 3.94M
FCF (ttm) -24.72M
Book/sh 0.69
Cash/sh 0.08
Employees —
Insider 10d —
IPO Dec 08, 2022
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E —
PEG —
P/S 19.40
P/B 1.26
P/C —
EV/EBITDA —
EV/Sales 18.66
Quick Ratio 0.25
Current Ratio 0.83
Debt/Eq 6.51
LT Debt/Eq —
EPS (ttm) -0.31
EPS next Y —
EPS Growth —
Revenue Growth —
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-02-13
Earnings (prior) 2026-02-13
ROA -13.96%
ROE -47.41%
ROIC —
Gross Margin 79.99%
Oper. Margin -133.17%
Profit Margin 0.00%
Shs Outstand 88.28M
Shs Float 14.13M
Insider Own 83.89%
Instit Own 7.79%
Short Float 4.21%
Short Ratio 4.76
Short Interest 934.87K
52W High 6.19
vs 52W High -86.00%
52W Low 0.49
vs 52W Low 76.56%
Beta 3.43
Impl. Vol. —
Rel Volume 0.16
Avg Volume 260.02K
Volume 41.47K
Target (mean) $6.00
Tgt Median $6.00
Tgt Low $6.00
Tgt High $6.00
# Analysts 1
Recom None
Prev Close $0.87
Price $0.87
Change -0.15%
About

Citius Oncology, Inc. focuses on the development and commercialization of innovative targeted oncology therapies. It also engages in the development of LYMPHIR, an orphan indication for the treatment of adult patients with relapsed or refractory cutaneous T-cell lymphoma, a rare form of non-Hodgkin lymphoma. The company is headquartered in Cranford, New Jersey. Citius Oncology, Inc. is a subsidiary of Leonard-Meron Biosciences, Inc.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$6.00
Mean price target
2. Current target
$0.87
Latest analyst target
3. DCF / Fair value
$-5.04
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.87
Low
$6.00
High
$6.00
Mean
$6.00

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2025-09-23 up Maxim Group Hold → Buy $6
2025-05-23 down Maxim Group Buy → Hold —
2024-11-27 init Maxim Group — → Buy $3
2024-08-13 main EF Hutton Buy → Buy $6
News
RSS: Latest CTOR news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2025-09-19 MCGRATH DENNIS M Director — 300,000 $0.00 $0
2025-09-19 MCGRATH DENNIS M Director — 300,000 $0.00 $0
2025-09-19 MCGRATH DENNIS M Director — 300,000 $0.00 $0
2025-09-19 MAZUR LEONARD L Chief Executive Officer — 1,700,000 $0.00 $0
2025-09-19 MAZUR LEONARD L Chief Executive Officer — 1,700,000 $0.00 $0
2025-09-19 MAZUR LEONARD L Chief Executive Officer — 1,700,000 $0.00 $0
2025-09-19 DUTIA SUREN G Director — 300,000 $0.00 $0
2025-09-19 DUTIA SUREN G Director — 300,000 $0.00 $0
2025-09-19 DUTIA SUREN G Director — 300,000 $0.00 $0
2025-09-19 MAYERSOHN JOEL DAVID Director — 300,000 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-09-30 2024-09-30 2023-09-30 2022-09-30
Total Revenue
0.00
0.00
0.00
0.00
Operating Revenue
0.00
0.00
0.00
0.00
Operating Expense
23.52
+14.34%
20.57
+69.72%
12.12
+149.58%
4.86
Research And Development
6.42
+30.32%
4.93
+16.14%
4.24
+23.71%
3.43
Selling General And Administration
17.10
+9.31%
15.65
+98.56%
7.88
+451.59%
1.43
General And Administrative Expense
17.10
+9.31%
15.65
+98.56%
7.88
+451.59%
1.43
Salaries And Wages
8.32
+10.96%
7.50
+281.52%
1.97
0.00
Other Gand A
8.78
+7.79%
8.15
+37.76%
5.92
+314.02%
1.43
Total Expenses
23.52
+14.34%
20.57
+69.72%
12.12
+149.58%
4.86
Operating Income
-23.52
-14.34%
-20.57
-69.72%
-12.12
-149.58%
-4.86
Total Operating Income As Reported
-23.52
-14.34%
-20.57
—
—
EBITDA
-23.49
-14.16%
-20.57
-69.72%
-12.12
-149.58%
-4.86
Normalized EBITDA
-23.49
-14.16%
-20.57
-69.72%
-12.12
-149.58%
-4.86
EBIT
-23.49
-14.16%
-20.57
-69.72%
-12.12
-149.58%
-4.86
Net Income
-24.76
-17.08%
-21.15
-66.56%
-12.70
-133.72%
-5.43
Pretax Income
-23.70
-15.22%
-20.57
-69.72%
-12.12
-149.58%
-4.86
Net Non Operating Interest Income Expense
-0.18
0.00
—
—
Interest Expense Non Operating
0.22
0.00
—
—
Net Interest Income
-0.18
0.00
—
—
Interest Expense
0.22
0.00
—
—
Interest Income Non Operating
0.04
0.00
—
—
Interest Income
0.04
0.00
—
—
Tax Provision
1.06
+83.50%
0.58
+0.00%
0.58
+0.00%
0.58
Tax Rate For Calcs
0.00
+0.00%
0.00
+0.00%
0.00
+0.00%
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-24.76
-17.08%
-21.15
-66.56%
-12.70
-133.72%
-5.43
Net Income From Continuing Operation Net Minority Interest
-24.76
-17.08%
-21.15
-66.56%
-12.70
-133.72%
-5.43
Net Income From Continuing And Discontinued Operation
-24.76
-17.08%
-21.15
-66.56%
-12.70
-133.72%
-5.43
Net Income Continuous Operations
-24.76
-17.08%
-21.15
-66.56%
-12.70
-133.72%
-5.43
Normalized Income
-24.76
-17.08%
-21.15
-66.56%
-12.70
-133.72%
-5.43
Net Income Common Stockholders
-24.76
-17.08%
-21.15
-66.56%
-12.70
-133.72%
-5.43
Diluted EPS
-0.34
-9.68%
-0.31
-73.93%
-0.18
-133.72%
-0.08
Basic EPS
-0.34
-9.68%
-0.31
-73.93%
-0.18
-133.72%
-0.08
Basic Average Shares
73.27
+7.66%
68.05
-4.47%
71.24
+0.00%
71.24
Diluted Average Shares
73.27
+7.66%
68.05
-4.47%
71.24
+0.00%
71.24
Diluted NI Availto Com Stockholders
-24.76
-17.08%
-21.15
-66.56%
-12.70
-133.72%
-5.43
Line Item Trend 2025-09-30 2024-09-30 2023-09-30 2022-09-30
Total Assets
100.94
+19.64%
84.37
+76.74%
47.73
+11.82%
42.69
Current Assets
27.54
+151.10%
10.97
+41.81%
7.73
+187.52%
2.69
Cash Cash Equivalents And Short Term Investments
3.92
+3504282.14%
0.00
0.00
0.00
Cash And Cash Equivalents
3.92
+3504282.14%
0.00
0.00
0.00
Inventory
22.29
+169.53%
8.27
0.00
—
Work In Process
11.71
+448.71%
2.13
—
—
Finished Goods
10.58
+72.42%
6.13
—
—
Prepaid Assets
1.33
-50.69%
2.70
-65.09%
7.73
+187.52%
2.69
Total Non Current Assets
73.40
+0.00%
73.40
+83.50%
40.00
+0.00%
40.00
Goodwill And Other Intangible Assets
73.40
+0.00%
73.40
+83.50%
40.00
+0.00%
40.00
Other Intangible Assets
73.40
+0.00%
73.40
+83.50%
40.00
+0.00%
40.00
Total Liabilities Net Minority Interest
56.08
+46.69%
38.23
+72.21%
22.20
+245.63%
6.42
Current Liabilities
49.49
+51.35%
32.70
+55.37%
21.05
+259.98%
5.85
Payables And Accrued Expenses
49.49
+51.35%
32.70
+55.37%
21.05
+259.98%
5.85
Payables
45.40
+38.83%
32.70
+57.30%
20.79
+334.36%
4.79
Accounts Payable
13.23
+256.57%
3.71
+187.94%
1.29
+1296.42%
0.09
Other Payable
22.65
-20.25%
28.40
—
—
Current Accrued Expenses
4.09
0.00
-100.00%
0.26
-75.58%
1.06
Other Current Liabilities
—
0.00
—
—
Total Non Current Liabilities Net Minority Interest
6.59
+19.12%
5.53
+379.87%
1.15
+100.00%
0.58
Long Term Debt And Capital Lease Obligation
3.80
+0.00%
3.80
—
—
Long Term Debt
3.80
+0.00%
3.80
—
—
Non Current Deferred Liabilities
2.78
+61.17%
1.73
+50.00%
1.15
+100.00%
0.58
Non Current Deferred Taxes Liabilities
2.78
+61.17%
1.73
+50.00%
1.15
+100.00%
0.58
Other Non Current Liabilities
—
-0.00
—
—
Stockholders Equity
44.87
-2.76%
46.14
+80.69%
25.54
-29.59%
36.27
Common Stock Equity
44.87
-2.76%
46.14
+80.69%
25.54
-29.59%
36.27
Capital Stock
0.01
+16.72%
0.01
+6.00%
0.01
+0.00%
0.01
Common Stock
0.01
+16.72%
0.01
+6.00%
0.01
+0.00%
0.01
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
83.51
+16.72%
71.55
+0.44%
71.24
+0.00%
71.24
Ordinary Shares Number
83.51
+16.72%
71.55
+0.44%
71.24
+0.00%
71.24
Additional Paid In Capital
108.90
+27.50%
85.41
+95.63%
43.66
+4.71%
41.69
Retained Earnings
-64.04
-63.04%
-39.28
-116.65%
-18.13
-233.72%
-5.43
Total Equity Gross Minority Interest
44.87
-2.76%
46.14
+80.69%
25.54
-29.59%
36.27
Total Capitalization
48.67
-2.55%
49.94
+95.57%
25.54
-29.59%
36.27
Working Capital
-21.95
-1.00%
-21.73
-63.24%
-13.31
-321.73%
-3.16
Invested Capital
48.67
-2.55%
49.94
+95.57%
25.54
-29.59%
36.27
Total Debt
3.80
+0.00%
3.80
—
—
Net Debt
—
3.80
—
—
Net Tangible Assets
-28.53
-4.67%
-27.26
-88.46%
-14.46
-287.51%
-3.73
Tangible Book Value
-28.53
-4.67%
-27.26
-88.46%
-14.46
-287.51%
-3.73
Dueto Related Parties Current
9.51
+1515.77%
0.59
-96.98%
19.50
+315.44%
4.69
Line Item Trend 2025-09-30 2024-09-30 2023-09-30 2022-09-30
Operating Cash Flow
-5.49
-4446.59%
0.13
0.00
0.00
Cash Flow From Continuing Operating Activities
-5.49
-4446.59%
0.13
0.00
0.00
Net Income From Continuing Operations
-24.76
-17.08%
-21.15
-66.56%
-12.70
-133.72%
-5.43
Stock Based Compensation
8.32
+10.96%
7.50
+281.52%
1.97
0.00
Deferred Tax
1.06
+83.50%
0.58
+0.00%
0.58
+0.00%
0.58
Deferred Income Tax
1.06
+83.50%
0.58
+0.00%
0.58
+0.00%
0.58
Change In Working Capital
9.89
-25.06%
13.20
+29.98%
10.16
+109.11%
4.86
Change In Inventory
-12.65
-492.78%
-2.13
0.00
—
Change In Prepaid Assets
0.00
+100.00%
-1.10
+78.19%
-5.04
-409.47%
-0.99
Change In Payables And Accrued Expense
22.54
+37.16%
16.43
+8.12%
15.20
+159.98%
5.85
Change In Accrued Expense
4.09
+1679.92%
-0.26
+67.69%
-0.80
-175.58%
1.06
Change In Payable
18.45
+10.51%
16.69
+4.32%
16.00
+234.36%
4.79
Change In Account Payable
9.52
+293.10%
2.42
+102.43%
1.20
+1196.42%
0.09
Investing Cash Flow
-5.75
-15.00%
-5.00
0.00
—
Cash Flow From Continuing Investing Activities
-5.75
-15.00%
-5.00
0.00
—
Capital Expenditure
-5.75
-15.00%
-5.00
—
—
Net Intangibles Purchase And Sale
-5.75
-15.00%
-5.00
0.00
—
Purchase Of Intangibles
-5.75
-15.00%
-5.00
0.00
—
Financing Cash Flow
15.17
+211.19%
4.87
0.00
—
Cash Flow From Continuing Financing Activities
15.17
+211.19%
4.87
0.00
—
Net Issuance Payments Of Debt
0.00
-100.00%
3.80
0.00
—
Issuance Of Debt
0.00
-100.00%
3.80
0.00
—
Long Term Debt Issuance
0.00
-100.00%
3.80
0.00
—
Net Long Term Debt Issuance
0.00
-100.00%
3.80
0.00
—
Net Common Stock Issuance
15.17
0.00
—
—
Net Other Financing Charges
—
1.07
—
—
Changes In Cash
3.92
+3504182.14%
0.00
—
—
Beginning Cash Position
0.00
0.00
0.00
0.00
End Cash Position
3.92
+3504282.14%
0.00
0.00
0.00
Free Cash Flow
-11.24
-130.67%
-4.87
0.00
0.00
Common Stock Issuance
15.17
0.00
—
—
Issuance Of Capital Stock
15.17
0.00
—
—
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category